Empagliflozin
Brand name: Jardiance
Rank #3 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$3.58B
Total Cost
3,334,784
Total Claims
$3.58B
Total Cost
71,367
Prescribers
$1,074
Cost per Claim
637,917
Beneficiaries
6,148,290
30-Day Fills
$50K
Avg Cost/Provider
47
Avg Claims/Provider
Share of Medicare Part D Spending
1.3%
of total Medicare Part D spending
$3.58B of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $3.58B total
🔎 Data Overview
Empagliflozin is the #3 most expensive drug in Medicare Part D, costing taxpayers $3.58B in 2023. The top 10 drugs alone account for roughly 20% of all Part D spending.
At $1,074 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $5,615 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Empagliflozin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Enrique Griego | Family Practice | Mcallen, TX | 1,015 | $1.4M |
| 2 | Mauricio Melhado | Cardiology | West Palm Beach, FL | 1,562 | $1.3M |
| 3 | Bashar Saad | Endocrinology | San Dimas, CA | 1,541 | $1.2M |
| 4 | Vasdev Lohano | Endocrinology | Washington, IN | 1,311 | $1.2M |
| 5 | Cres Miranda | Cardiology | Las Vegas, NV | 820 | $1.2M |
| 6 | Michael Lin | Endocrinology | San Gabriel, CA | 1,192 | $1.1M |
| 7 | Helen Slone | Endocrinology | Vineland, NJ | 758 | $1.0M |
| 8 | Mohammad Ijaz | Endocrinology | Zanesville, OH | 941 | $979K |
| 9 | Junho Lee | Internal Medicine | Flushing, NY | 941 | $940K |
| 10 | Amer Issa | Endocrinology | Saginaw, MI | 736 | $908K |
| 11 | Thomas-Duythuc To | Cardiology | Reno, NV | 677 | $903K |
| 12 | Mark Hoffmann | Interventional Cardiology | Wausau, WI | 714 | $880K |
| 13 | Hasan Qutob | Endocrinology | Jackson, MI | 815 | $867K |
| 14 | Phong Bui | Internal Medicine | Fountain Valley, CA | 726 | $856K |
| 15 | Dae Rheem | Gastroenterology | Los Angeles, CA | 1,049 | $804K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 1 | Apixaban (Eliquis) | $7.75B | 8,995,930 |
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
| 6 | Adalimumab (Humira(Cf) Pen) | $2.17B | 240,925 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology